🔎 Trials Near Me

Home › Castration-Resistant Prostatic Cancer › Ohio

Castration-Resistant Prostatic Cancer clinical trials in Ohio

3 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in Ohio.

Cities in Ohio

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • University of Cincinnati, Cincinnati
  • University Hospital of Cleveland, Cleveland
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07164443

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Gabrail Cancer Center, Canton
  • University of Cincinnati, Cincinnati
  • Metrohealth Medical Center, Cleveland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07225946

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  • University of Cincinnati Medical Center, Cincinnati
  • The Ohio State University, Columbus
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Oct 29, 2026 · NCT05519449

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.